Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
| Company Name | Founded | Funding Stage | Amount | City |
|---|---|---|---|---|
| Nyobolt | 2026 | Series C | $30.0M | Cambridge |
| Neurovalens | 2026 | Grant | $6.8M | Belfast |
| Torus | 2026 | Debt Financing | $200.0M | South Salt Lake |
| Isembard | 2026 | Series A | $50.0M | London |
| Subbyx | 2026 | Series A | $34.8M | Milan |
| Tropic Biosciences | 2026 | Series C | $105.0M | London |
| Trogenix | 2025 | Series A | $94.1M | Edinburgh |
| AiM Medical Robotics | 2025 | Series A | $8.1M | Worcester |
| Synthesized | 2025 | Series A | $20.0M | London |
| DaltonTx | 2025 | Seed | $5.4M | London |
| # | Company | Stage | Amount | Location |
|---|---|---|---|---|
| 1 | Nyobolt | Series C | $30.0M | Cambridge, United Kingdom |
| 2 | Neurovalens | Grant | $6.8M | Belfast, United Kingdom |
| 3 | Torus | Debt Financing | $200.0M | South Salt Lake, United States |
| 4 | Isembard | Series A | $50.0M | London, United Kingdom |
| 5 | Subbyx | Series A | $34.8M | Milan, Italy |
| 6 | Tropic Biosciences | Series C | $105.0M | London, United Kingdom |
| 7 | Trogenix | Series A | $94.1M | Edinburgh, United Kingdom |
| 8 | AiM Medical Robotics | Series A | $8.1M | Worcester, United States |
| 9 | Synthesized | Series A | $20.0M | London, United Kingdom |
| 10 | DaltonTx | Seed | $5.4M | London, United Kingdom |
Nyobolt develops high-power energy storage systems based on advanced lithium-ion battery technology.
Neurovalens delivers innovative solutions in the field of neuroscience, bioscience and neurophysiology
Torus empowers individuals and communities to become their renewable energy providers.
Isembard creates automated, software-powered factories for high-precision manufacturing in aerospace, defence, and energy.
Subbyx provides long-term subscriptions for technology products and small home appliances.
Tropic Biosciences is a pioneering leader in the development of novel high-performing commercial tropical crop varieties and traits.
Trogenix is a biotech company that develops precision cancer treatments that selectively target diseased cell states and behaviour.
AiM Medical Robotics is a biotechnology company developing a robotic system for use in neurosurgical procedures.
Deliver compliant production-like data to testing and development teams for any scenario
DaltonTx is redefining how technology powers drug discovery creating the intelligence.
Lead is a Banking as a Service platform providing financial solutions for individuals, businesses, and fintech companies.
Paragraf develops and manufactures graphene-based electronic devices for the sensors and diagnostics markets.
QuadSAT has been established as a VSAT solution and R&D company in Horsens, Denmark.
Virtru provides data encryption for email and file sharing, enabling users to easily control access to their sensitive data.
AccelerComm is a semiconductor IP-core company specialising in channel coding solutions.
Valarian Technologies is a provider of data sovereignty infrastructure for enterprises and government institutions.
Sanity is a platform for structured content that lets teams build digital experiences.
Code Optimisation Platform
Alpine Eagle is a mix of software and hardware focused on cost efficiency.
Cambridge GaN Devices is a semiconductor company focused on developing GaN power devices aimed at creating greener electronics.
IONATE creates energy solutions with hybrid intelligent transformers and AI-driven grid management for a more efficient power system.
Mindgard empowers enterprise security teams to deploy AI and GenAI securely.
Planetary does coastal carbon removal through ocean alkalinity enhancement.
The leader in private AI.
ST Labs is an AI service management platform handling requests and incidents to reduce manual coordination required to deliver IT services.
IQ Capital has invested in 133 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
IQ Capital's top investment sectors include Manufacturing, Biotechnology, Software, Information Technology, Artificial Intelligence (AI). The firm invests across 60 different industry categories.
Among tracked funding rounds, Torus received $200.0M in a Debt Financing round. IQ Capital's total known invested capital is $1.2B.
IQ Capital's average investment size is $20.6M across its portfolio of 133 companies.
Recent IQ Capital portfolio additions include Nyobolt, Neurovalens, Torus, Isembard, Subbyx. These companies were founded in 2020 or later.
Discover portfolio companies of other leading venture capital firms and investors.
View All Investors